z-logo
Premium
Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
Author(s) -
Ohashi K,
Warrington SJ,
Kaye CM,
Houghton GW,
Dennis M,
Templeton R,
Turner P
Publication year - 1981
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1981.tb01265.x
Subject(s) - acebutolol , metabolite , heart rate , placebo , medicine , dose–response relationship , pharmacology , pharmacokinetics , chemistry , endocrinology , blood pressure , alternative medicine , pathology
1 The pharmacological effects and plasma levels of diacetolol, the major human metabolite of acebutolol, were measured in a double‐blind, balanced study in which five healthy men received single oral doses of diacetolol 100, 200, 400 and 800 mg, or placebo, at weekly intervals. 2 Resting and exercise heart rate (HR), forced expiratory volume in 1 second (FEV1), resting and exercise peak expiratory flow rate (PEFR), and plasma concentrations of diacetolol were determined at 0, 2, 4, 6, 8 and 24 h after each treatment. 3 Diacetolol caused a slight dose‐ related reduction in resting HR and a substantial dose‐related reduction in exercise HR. AT the same time it was found that diacetolol had no significant effects on FEV1 and resting and exercise PEFR. 4 Mean highest observed plasma concentrations (ng/ml) of diacetolol were 177 at a mean of 4.4 h after the 100 mg dose, 243 at 4.0 h after the 200 mg dose, 807 at 5.2 h after the 400 mg dose, and 1,306 at 4.4 h after the 800 mg dose. 5 Using the mean data, there was a strong correlation (r = 0.90) between % reduction in exercise HR and the logarithm of the plasma concentration of diacetolol. 6 Diacetolol exhibits marked cardiac beta‐adrenoceptor blocking activity in man which is still evident 24 h after the administration of the higher doses of the drug. No adverse effects on pulmonary function could be detected.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here